Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Numab Therapeutics Achieves Milestone in Second
Numab Therapeutics AG | About us
Novo Holdings portfolio company Numab Therapeutics announces Johnson ...
Numab Therapeutics and Kaken Pharmaceutical Announce Licensing and Co ...
Numab Therapeutics AG – Swiss Biotech
Numab Therapeutics AG | S-GE
Numab is pleased to announce the start of a Phase 1 clinical trial ...
Numab Therapeutics AG on LinkedIn: #hiring #hiringnow
Numab Therapeutics AG on LinkedIn: #atopicdermatitis
#atopicdermatitis #firstpatient #clinicaltrials #inflammation | Numab ...
Numab Therapeutics AG op LinkedIn: #immunotherapy
Numab Therapeutics AG on LinkedIn: #ror1 #sitc2021
Numab Therapeutics AG on LinkedIn: #immunooncology #aacr22
Numab Therapeutics AG on LinkedIn: We are proud to announce the closing ...
#sitc2022 #immunooncology | Numab Therapeutics AG
Numab Therapeutics AG on LinkedIn: #biopharma #cancer #immunotherapy
Numab Therapeutics-Numab Therapeutics AG-企业详情-InvestGO数据库-ByDrug-医药魔方数据库
Numab Therapeutics AG on LinkedIn: #atopicdermatitis #eadvcongress
Numab Therapeutics AG on LinkedIn: #immunotherapy #antibody #ProteinSummit
Numab Therapeutics AG | LinkedIn
Numab & Kaken Team Up on NM81 for IBD Treatment
Numab Therapeutics AG
Numab Therapeutics AG - Venturelab
Numab Therapeutics AG | Our Science
Numab Therapeutics
Numab Therapeutics AG on LinkedIn: We are happy to announce today that ...
Numab Therapeutics AG (Numab Therapeutics AG) - 药物管线_专利_临床试验_投融营收_最新药物 ...
Numab Therapeutics raises $55M for antibody-based immunotherapies - Tech.eu
We are delighted to welcome Mireia G. to Numab Therapeutics AG as a ...
Numab Therapeutics Initiates Phase 1 Trial for NM32 in Solid Tumors
Physiomics plc on LinkedIn: Together with Numab Therapeutics AG, we ...
Congratulations to Numab Therapeutics AG on acquiring Yellow Jersey ...
Numab Therapeutics AG on LinkedIn: Congratulations to our partner ...
Numab Therapeutics AG | Careers
BioCentury - J&J adds bispecific for atopic dermatitis via deal with Numab
Numab Therapeutics Launches Cancer Antibody Deal with Ono
Numab linked in_test | PPT
Numab Therapeutics Secures $55M to Advance Antibody-Based Immunotherapy ...
Numab Therapeutics' spin-off, Yellow Jersey Therapeutics, gets acquired ...
Numab Therapeutics AG on LinkedIn: Numab poster presentation at AACR20 ...
Numab links up with German pharma major on cancer and retinal diseases ...
Numab Therapeutics AG | Numab Therapeutics AG
Numab Therapeutics AG - startup.ch
Numab Therapeutics and Boehringer Ingelheim Enter into Collaboration to ...
Numab Therapeutics Org Chart + Executive Team
NUMAB THERAPEUTICS | DxMultiomics
Numab Therapeutics AG. (1/9/25). "Press Release: Numab Therapeutics ...
Numab Therapeutics acquires NM26 antibody for atopic dermatitis ...
MUFG Capital joins Zurich-based Numab Therapeutics' $22.6m Series B
Numab Therapeutics raises 100 million Swiss francs | Greater Zurich
Numab Therapeutics and Ono Pharma Partner To Develop Multi-specific ...
Numab Therapeutics AG on LinkedIn: #tbt #zukunfstag
Numab Therapeutics deepens financial ties with Ono Pharma | Swiss ...
Numab Therapeutics expandiert - Horgen labs
Numab Therapeutics Announces Series C Extension to CHF 180 Million ...
Numab a levé 100 millions et défie les plus grands | Republic of Innovation
J&J snaps up atopic dermatitis drug in $1.25bn Numab deal | pharmaphorum
Numab Therapeutics Announces First Subject Dosed in Ph 1 trial of NM26 ...
Numab Therapeutics宣布在NM26治疗中度至重度特应性皮炎的多次递增剂量1期研究中完成首例患者给药-动脉网
Numab Therapeutics sells subsidiary to Johnson & Johnson | S-GE
#nm32 #sitc2021 | Numab Therapeutics AG
Numab raises $111M to challenge Genmab, BioNTech for emerging PD-L1 ...
Numab Therapeutics AG on LinkedIn: We have dosed the first patient in ...
Numab Therapeutics Announces Johnson & Johnson to Acquire its ...
Portfolio Company Numab Therapeutics Update | Shares Magazine
In this multi-faceted position, you will contribute to driving Numab’s ...
Invest Europe - who we are | Invest Europe
Internship in Formulation & Analytics 60% - 100%, Temporary for 3 ...
Berufswahl-Portal
May 15 2023
三抗技术梳理 本文转载自“医药笔记”微信公众号，作者：Armstrong2021年8月27日，启愈生物TAA/CTLA-4/IL-15... - 雪球
瑞士生物科技公司Numab Therapeutics研发多特异性抗体药物，提升癌症与炎症治愈率 | 瑞士创新100强-36氪
Roland Helfenstein on LinkedIn: Excited to share that Ono ...
Johnson & Johnson Secures Numab's Experimental Antibody for Atopic ...
兔单抗：抗体开发平台新选择 2020年3月9日，瑞士Numab Therapeutics AG公司（以下简称“Numab公司”）宣布完成 ...
瑞士生物科技公司Numab Therapeutics研发多特异性抗体药物，提升癌症与炎症治愈率 | 瑞士创新100强|多特蒙德_新浪财经_新浪网
12.5亿美元！强生最新收购，又收获一款双抗 5月28日， 强生 宣布与Numab Therapeutics 达成最终协议，强生将以约12.5 ...
David Urech posted on LinkedIn
Johnson & Johnson Acquires Numab’s Investigational Antibody for the ...
S²CUBE丨瑞士生物科技公司Numab Therapeutics研发多特异性抗体药物，提升癌症与炎症治愈率医药新闻-ByDrug-一站式医药 ...
研发多特异性抗体，Numab Therapeutics获「三生国健」领投2200万瑞士法郎B轮融资-36氪
